0001806310-20-000001.txt : 20200504 0001806310-20-000001.hdr.sgml : 20200504 20200501190712 ACCESSION NUMBER: 0001806310-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200504 DATE AS OF CHANGE: 20200501 EFFECTIVENESS DATE: 20200504 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Taysha Gene Therapies, Inc. CENTRAL INDEX KEY: 0001806310 IRS NUMBER: 843199512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-366194 FILM NUMBER: 20842278 BUSINESS ADDRESS: STREET 1: 7318 MORTON STREET CITY: DALLAS STATE: TX ZIP: 75209 BUSINESS PHONE: 212.551.8702 MAIL ADDRESS: STREET 1: 7318 MORTON STREET CITY: DALLAS STATE: TX ZIP: 75209 D 1 primary_doc.xml X0708 D LIVE 0001806310 Taysha Gene Therapies, Inc. 7318 MORTON STREET DALLAS TX TEXAS 75209 212.551.8702 DELAWARE None None Corporation true 2019 R.A. Session II 7318 Morton Street Dallas TX TEXAS 75209 Executive Officer Director Sean Nolan 7318 Morton Street Dallas TX TEXAS 75209 Director Paul B. Manning 7318 Morton Street Dallas TX TEXAS 75209 Director Biotechnology Decline to Disclose 06b false 2020-03-04 true true false 0 Chardon Capital Markets LLC 120128 None None 17 State Street Suite 2130 New York NY NEW YORK 10004 All States false 30000000 18000000 12000000 false 9 0 435000 $261,000 at initial closing. $174,000 to be paid upon future closing. 0 false Taysha Gene Therapies, Inc. /s/ R.A. Session II R.A. Session II President 2020-05-01